Georgia
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 1.48 (1.46 - 1.50) | 2019 | Modelled | IHME |
| 1.49 (1.48 - 1.51) | 2018 | Modelled | IHME |
| 1.51 (1.49 - 1.53) | 2017 | Modelled | IHME |
| 1.54 (1.52 - 1.56) | 2016 | Modelled | IHME |
| 1.57 (1.55 - 1.59) | 2015 | Modelled | IHME |
| 1.61 (1.59 - 1.63) | 2014 | Modelled | IHME |
| 1.65 (1.63 - 1.67) | 2013 | Modelled | IHME |
| 1.69 (1.67 - 1.71) | 2012 | Modelled | IHME |
| 1.73 (1.71 - 1.75) | 2011 | Modelled | IHME |
| 1.76 (1.74 - 1.78) | 2010 | Modelled | IHME |
| 1.79 (1.76 - 1.81) | 2009 | Modelled | IHME |
| 1.81 (1.79 - 1.83) | 2008 | Modelled | IHME |
| 1.83 (1.81 - 1.85) | 2007 | Modelled | IHME |
| 1.85 (1.82 - 1.87) | 2006 | Modelled | IHME |
| 1.87 (1.84 - 1.90) | 2005 | Modelled | IHME |
| 1.9 (1.87 - 1.93) | 2004 | Modelled | IHME |
| 1.93 (1.90 - 1.96) | 2003 | Modelled | IHME |
| 1.97 (1.93 - 2) | 2002 | Modelled | IHME |
| 1.99 (1.95 - 2.03) | 2001 | Modelled | IHME |
| 2 (1.96 - 2.04) | 2000 | Modelled | IHME |
| 2 (1.96 - 2.03) | 1999 | Modelled | IHME |
| 1.99 (1.95 - 2.02) | 1998 | Modelled | IHME |
| 1.97 (1.94 - 2.01) | 1997 | Modelled | IHME |
| 1.96 (1.93 - 2) | 1996 | Modelled | IHME |
| 1.95 (1.92 - 1.99) | 1995 | Modelled | IHME |
| 1.95 (1.91 - 1.98) | 1994 | Modelled | IHME |
| 1.94 (1.91 - 1.98) | 1993 | Modelled | IHME |
| 1.94 (1.90 - 1.98) | 1992 | Modelled | IHME |
| 1.94 (1.90 - 1.98) | 1991 | Modelled | IHME |
| 1.93 (1.89 - 1.98) | 1990 | Modelled | IHME |
| 2.09 (1.48 - 2.83) | 2015 | Modelled | WHO |
| 2.5 (1.90 - 3) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
| 2.9 (2.38 - 3.51) | 2017 | Survey/reported | Kasradze et al, 2017 |
| 2.64 (2.22 - 3.14) | 2013 | Modelled | Schweitzer et al, 2015 |
Showing out of
Show more
Children under-5 years
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0.24 (0.21 - 0.28) | 2019 | Modelled | IHME |
| 0.26 (0.23 - 0.28) | 2018 | Modelled | IHME |
| 0.26 (0.23 - 0.29) | 2017 | Modelled | IHME |
| 0.26 (0.23 - 0.29) | 2016 | Modelled | IHME |
| 0.26 (0.22 - 0.30) | 2014 | Modelled | IHME |
| 0.27 (0.23 - 0.31) | 2013 | Modelled | IHME |
| 0.28 (0.24 - 0.32) | 2012 | Modelled | IHME |
| 0.29 (0.24 - 0.33) | 2011 | Modelled | IHME |
| 0.31 (0.25 - 0.34) | 2010 | Modelled | IHME |
| 0.34 (0.29 - 0.38) | 2009 | Modelled | IHME |
| 0.41 (0.35 - 0.45) | 2008 | Modelled | IHME |
| 0.49 (0.43 - 0.54) | 2007 | Modelled | IHME |
| 0.58 (0.51 - 0.64) | 2006 | Modelled | IHME |
| 0.67 (0.58 - 0.75) | 2005 | Modelled | IHME |
| 0.76 (0.64 - 0.85) | 2004 | Modelled | IHME |
| 0.85 (0.70 - 0.98) | 2003 | Modelled | IHME |
| 0.95 (0.75 - 1.11) | 2002 | Modelled | IHME |
| 1.05 (0.80 - 1.23) | 2001 | Modelled | IHME |
| 1.13 (0.86 - 1.33) | 2000 | Modelled | IHME |
| 1.21 (0.94 - 1.41) | 1999 | Modelled | IHME |
| 1.31 (1.05 - 1.49) | 1998 | Modelled | IHME |
| 1.39 (1.16 - 1.56) | 1997 | Modelled | IHME |
| 1.45 (1.24 - 1.61) | 1996 | Modelled | IHME |
| 1.47 (1.27 - 1.64) | 1995 | Modelled | IHME |
| 1.47 (1.27 - 1.63) | 1994 | Modelled | IHME |
| 1.47 (1.26 - 1.63) | 1993 | Modelled | IHME |
| 1.46 (1.24 - 1.62) | 1992 | Modelled | IHME |
| 1.45 (1.19 - 1.62) | 1991 | Modelled | IHME |
| 1.42 (1.13 - 1.63) | 1990 | Modelled | IHME |
| 0.26 (0.16 - 0.42) | 2015 | Modelled | WHO |
Showing out of
Show more
Number of people living with chronic HBV
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 106,533 (103,946 - 108,886) | 1990 | Modelled | IHME |
| 105,927 (103,700 - 108,068) | 1991 | Modelled | IHME |
| 105,051 (103,036 - 107,037) | 1992 | Modelled | IHME |
| 103,936 (101,981 - 105,869) | 1993 | Modelled | IHME |
| 102,664 (100,863 - 104,503) | 1994 | Modelled | IHME |
| 101,322 (99,539 - 103,181) | 1995 | Modelled | IHME |
| 100,094 (98,466 - 101,824) | 1996 | Modelled | IHME |
| 98,977 (97,359 - 100,659) | 1997 | Modelled | IHME |
| 97,776 (96,072 - 99,477) | 1998 | Modelled | IHME |
| 96,369 (94,500 - 98,078) | 1999 | Modelled | IHME |
| 94,652 (92,656 - 96,403) | 2000 | Modelled | IHME |
| 92,303 (90,469 - 93,960) | 2001 | Modelled | IHME |
| 89,317 (87,677 - 90,779) | 2002 | Modelled | IHME |
| 86,053 (84,569 - 87,380) | 2003 | Modelled | IHME |
| 82,894 (81,552 - 84,061) | 2004 | Modelled | IHME |
| 80,154 (78,963 - 81,279) | 2005 | Modelled | IHME |
| 77,872 (76,826 - 78,884) | 2006 | Modelled | IHME |
| 75,841 (74,876 - 76,755) | 2007 | Modelled | IHME |
| 73,947 (73,028 - 74,852) | 2008 | Modelled | IHME |
| 72,084 (71,178 - 72,998) | 2009 | Modelled | IHME |
| 70,177 (69,255 - 71,041) | 2010 | Modelled | IHME |
| 68,102 (67,280 - 68,902) | 2011 | Modelled | IHME |
| 65,892 (65,131 - 66,649) | 2012 | Modelled | IHME |
| 63,684 (62,953 - 64,422) | 2013 | Modelled | IHME |
| 61,589 (60,900 - 62,333) | 2014 | Modelled | IHME |
| 59,688 (58,991 - 60,454) | 2015 | Modelled | IHME |
| 57,895 (57,270 - 58,551) | 2016 | Modelled | IHME |
| 56,348 (55,658 - 57,040) | 2017 | Modelled | IHME |
| 55,149 (54,532 - 55,797) | 2018 | Modelled | IHME |
| 54,203 (53,602 - 54,860) | 2019 | Modelled | IHME |
| 35,434 (30,470 - 40,935) | 1990 | Modelled | IHME |
| 35,819 (30,800 - 41,156) | 1991 | Modelled | IHME |
| 36,198 (31,152 - 41,503) | 1992 | Modelled | IHME |
| 36,562 (31,635 - 41,671) | 1993 | Modelled | IHME |
| 36,912 (31,948 - 41,922) | 1994 | Modelled | IHME |
| 37,246 (32,103 - 42,453) | 1995 | Modelled | IHME |
| 37,549 (32,413 - 42,626) | 1996 | Modelled | IHME |
| 37,819 (32,576 - 42,892) | 1997 | Modelled | IHME |
| 38,075 (32,518 - 43,195) | 1998 | Modelled | IHME |
| 38,334 (32,633 - 43,670) | 1999 | Modelled | IHME |
| 38,612 (33,004 - 44,195) | 2000 | Modelled | IHME |
| 38,927 (33,257 - 44,484) | 2001 | Modelled | IHME |
| 39,268 (33,737 - 44,765) | 2002 | Modelled | IHME |
| 39,590 (34,203 - 45,195) | 2003 | Modelled | IHME |
| 39,842 (34,258 - 45,465) | 2004 | Modelled | IHME |
| 39,970 (34,368 - 45,750) | 2005 | Modelled | IHME |
| 39,833 (34,439 - 45,295) | 2006 | Modelled | IHME |
| 39,401 (34,135 - 44,630) | 2007 | Modelled | IHME |
| 38,789 (33,926 - 43,787) | 2008 | Modelled | IHME |
| 38,131 (33,457 - 43,060) | 2009 | Modelled | IHME |
| 37,580 (32,923 - 42,405) | 2010 | Modelled | IHME |
| 37,198 (32,713 - 41,797) | 2011 | Modelled | IHME |
| 36,886 (32,482 - 41,375) | 2012 | Modelled | IHME |
| 36,569 (32,165 - 40,800) | 2013 | Modelled | IHME |
| 36,170 (31,624 - 40,502) | 2014 | Modelled | IHME |
| 35,604 (30,882 - 40,006) | 2015 | Modelled | IHME |
| 34,454 (30,068 - 38,740) | 2016 | Modelled | IHME |
| 33,693 (29,241 - 38,624) | 2017 | Modelled | IHME |
| 33,836 (29,317 - 38,359) | 2018 | Modelled | IHME |
| 34,067 (29,108 - 38,681) | 2019 | Modelled | IHME |
| 100,000 (76,000 - 117,000) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
Showing out of
Show more
HBV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 10 (7.31 - 13.50) | 2019 | Modelled | IHME |
| 9.57 (7.21 - 12.60) | 2018 | Modelled | IHME |
| 9.42 (7.11 - 12.30) | 2017 | Modelled | IHME |
| 9.7 (7.40 - 12.60) | 2016 | Modelled | IHME |
| 9.94 (7.63 - 12.80) | 2015 | Modelled | IHME |
| 10.1 (7.82 - 13.10) | 2014 | Modelled | IHME |
| 10.6 (8.06 - 13.70) | 2013 | Modelled | IHME |
| 10.9 (8.33 - 13.90) | 2012 | Modelled | IHME |
| 11.1 (8.53 - 14.10) | 2011 | Modelled | IHME |
| 11.1 (8.62 - 14.10) | 2010 | Modelled | IHME |
| 11.1 (8.69 - 14) | 2009 | Modelled | IHME |
| 11.1 (8.63 - 14) | 2008 | Modelled | IHME |
| 11 (8.55 - 13.90) | 2007 | Modelled | IHME |
| 11.2 (8.76 - 13.90) | 2006 | Modelled | IHME |
| 11.4 (8.80 - 14.10) | 2005 | Modelled | IHME |
| 11.6 (9.04 - 14.70) | 2004 | Modelled | IHME |
| 11.3 (8.69 - 14) | 2003 | Modelled | IHME |
| 11.2 (8.64 - 14) | 2002 | Modelled | IHME |
| 10.8 (8.40 - 13.70) | 2001 | Modelled | IHME |
| 10.7 (8.22 - 13.50) | 2000 | Modelled | IHME |
| 10.4 (7.99 - 13.20) | 1999 | Modelled | IHME |
| 9.76 (7.45 - 12.40) | 1998 | Modelled | IHME |
| 9.05 (6.82 - 11.50) | 1997 | Modelled | IHME |
| 8.65 (6.55 - 10.90) | 1996 | Modelled | IHME |
| 8.83 (6.72 - 11.20) | 1995 | Modelled | IHME |
| 9.25 (7.04 - 11.80) | 1994 | Modelled | IHME |
| 9.09 (6.81 - 11.60) | 1993 | Modelled | IHME |
| 9.3 (7.02 - 11.90) | 1992 | Modelled | IHME |
| 9.18 (6.85 - 11.80) | 1991 | Modelled | IHME |
| 8.97 (6.67 - 11.50) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 367 (268 - 493) | 2019 | Modelled | IHME |
| 354 (267 - 467) | 2018 | Modelled | IHME |
| 351 (265 - 459) | 2017 | Modelled | IHME |
| 365 (279 - 475) | 2016 | Modelled | IHME |
| 377 (290 - 484) | 2015 | Modelled | IHME |
| 388 (299 - 500) | 2014 | Modelled | IHME |
| 410 (311 - 531) | 2013 | Modelled | IHME |
| 424 (324 - 542) | 2012 | Modelled | IHME |
| 435 (336 - 554) | 2011 | Modelled | IHME |
| 443 (343 - 563) | 2010 | Modelled | IHME |
| 448 (351 - 566) | 2009 | Modelled | IHME |
| 455 (353 - 574) | 2008 | Modelled | IHME |
| 455 (354 - 576) | 2007 | Modelled | IHME |
| 472 (369 - 585) | 2006 | Modelled | IHME |
| 486 (377 - 604) | 2005 | Modelled | IHME |
| 508 (394 - 640) | 2004 | Modelled | IHME |
| 502 (386 - 624) | 2003 | Modelled | IHME |
| 508 (392 - 637) | 2002 | Modelled | IHME |
| 501 (389 - 634) | 2001 | Modelled | IHME |
| 507 (389 - 639) | 2000 | Modelled | IHME |
| 501 (385 - 638) | 1999 | Modelled | IHME |
| 480 (367 - 609) | 1998 | Modelled | IHME |
| 454 (342 - 575) | 1997 | Modelled | IHME |
| 441 (334 - 558) | 1996 | Modelled | IHME |
| 458 (349 - 583) | 1995 | Modelled | IHME |
| 487 (371 - 624) | 1994 | Modelled | IHME |
| 486 (364 - 623) | 1993 | Modelled | IHME |
| 504 (380 - 646) | 1992 | Modelled | IHME |
| 502 (375 - 647) | 1991 | Modelled | IHME |
| 494 (368 - 633) | 1990 | Modelled | IHME |
| 800 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 22 (16 - 30) | 2019 | Modelled | IHME |
| 22 (16 - 30) | 2018 | Modelled | IHME |
| 22 (16 - 30) | 2017 | Modelled | IHME |
| 22 (16 - 30) | 2016 | Modelled | IHME |
| 22 (16 - 30) | 2015 | Modelled | IHME |
| 23 (17 - 30) | 2014 | Modelled | IHME |
| 23 (17 - 31) | 2013 | Modelled | IHME |
| 23 (17 - 31) | 2012 | Modelled | IHME |
| 23 (17 - 31) | 2011 | Modelled | IHME |
| 23 (17 - 31) | 2010 | Modelled | IHME |
| 23 (17 - 31) | 2009 | Modelled | IHME |
| 23 (17 - 31) | 2008 | Modelled | IHME |
| 23 (17 - 31) | 2007 | Modelled | IHME |
| 23 (17 - 31) | 2006 | Modelled | IHME |
| 23 (16 - 31) | 2005 | Modelled | IHME |
| 23 (16 - 31) | 2004 | Modelled | IHME |
| 23 (17 - 32) | 2003 | Modelled | IHME |
| 24 (17 - 33) | 2002 | Modelled | IHME |
| 24 (17 - 33) | 2001 | Modelled | IHME |
| 24 (17 - 33) | 2000 | Modelled | IHME |
| 24 (17 - 33) | 1999 | Modelled | IHME |
| 24 (17 - 34) | 1998 | Modelled | IHME |
| 24 (17 - 33) | 1997 | Modelled | IHME |
| 24 (17 - 33) | 1996 | Modelled | IHME |
| 23 (17 - 32) | 1995 | Modelled | IHME |
| 23 (17 - 32) | 1994 | Modelled | IHME |
| 23 (16 - 31) | 1993 | Modelled | IHME |
| 23 (17 - 31) | 1992 | Modelled | IHME |
| 23 (16 - 31) | 1991 | Modelled | IHME |
| 23 (16 - 31) | 1990 | Modelled | IHME |
Showing out of
Show more
Coverage of HepB birth dose
Newborns
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 97 | 2018 | Survey/reported | WHO/UNICEF |
| 94 | 2017 | Survey/reported | WHO/UNICEF |
| 94 | 2016 | Survey/reported | WHO/UNICEF |
| 93 | 2015 | Survey/reported | WHO/UNICEF |
| 95 | 2014 | Survey/reported | WHO/UNICEF |
| 80 | 2013 | Survey/reported | WHO/UNICEF |
| 92 | 2012 | Survey/reported | WHO/UNICEF |
| 93 | 2011 | Survey/reported | WHO/UNICEF |
| 95 | 2010 | Survey/reported | WHO/UNICEF |
| 73 | 2009 | Survey/reported | WHO/UNICEF |
| 99 | 2008 | Survey/reported | WHO/UNICEF |
| 99 | 2007 | Survey/reported | WHO/UNICEF |
| 97 | 2006 | Survey/reported | WHO/UNICEF |
| 93 | 2005 | Survey/reported | WHO/UNICEF |
| 92 | 2004 | Survey/reported | WHO/UNICEF |
| 90 | 2003 | Survey/reported | WHO/UNICEF |
| 80 | 2002 | Survey/reported | WHO/UNICEF |
| 69 | 2001 | Survey/reported | WHO/UNICEF |
| 94 | 2019 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 93 | 2018 | Survey/reported | WHO/UNICEF |
| 91 | 2017 | Survey/reported | WHO/UNICEF |
| 92 | 2016 | Survey/reported | WHO/UNICEF |
| 94 | 2015 | Survey/reported | WHO/UNICEF |
| 91 | 2014 | Survey/reported | WHO/UNICEF |
| 96 | 2013 | Survey/reported | WHO/UNICEF |
| 92 | 2012 | Survey/reported | WHO/UNICEF |
| 89 | 2011 | Survey/reported | WHO/UNICEF |
| 95 | 2010 | Survey/reported | WHO/UNICEF |
| 54 | 2009 | Survey/reported | WHO/UNICEF |
| 89 | 2008 | Survey/reported | WHO/UNICEF |
| 94 | 2007 | Survey/reported | WHO/UNICEF |
| 84 | 2006 | Survey/reported | WHO/UNICEF |
| 79 | 2005 | Survey/reported | WHO/UNICEF |
| 64 | 2004 | Survey/reported | WHO/UNICEF |
| 48 | 2003 | Survey/reported | WHO/UNICEF |
| 51 | 2002 | Survey/reported | WHO/UNICEF |
| 61 | 2001 | Survey/reported | WHO/UNICEF |
| 55 | 2000 | Survey/reported | WHO/UNICEF |
| 94 | 2019 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 31 (16 - 271) | 2015 | Survey/reported | Georgia National Centre for Disease Control and Public Health, 2015; Curatio International Foundation, 2015; Eurasia Harm Reduction Network, 2015 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 3.9 (3.10 - 4.80) | 2015 | Survey/reported | Curatio International Foundation, 2015 |
HBV National Action Plan
HepB birth dose policy
Yes
Year of birth dose introduction
2003
Eligible for HBV generic medicines
HBV elimination goal
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
Risk-based, Birth cohort
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
None
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 3.48 (2.81 - 4.24) | 2019 | Modelled | IHME |
| 3.5 (2.82 - 4.26) | 2018 | Modelled | IHME |
| 3.51 (2.83 - 4.27) | 2017 | Modelled | IHME |
| 3.49 (2.84 - 4.26) | 2016 | Modelled | IHME |
| 3.48 (2.85 - 4.25) | 2015 | Modelled | IHME |
| 3.54 (2.93 - 4.29) | 2014 | Modelled | IHME |
| 3.68 (3.08 - 4.40) | 2013 | Modelled | IHME |
| 3.85 (3.26 - 4.54) | 2012 | Modelled | IHME |
| 4 (3.38 - 4.67) | 2011 | Modelled | IHME |
| 4.06 (3.44 - 4.75) | 2010 | Modelled | IHME |
| 4.06 (3.44 - 4.75) | 2009 | Modelled | IHME |
| 4.06 (3.44 - 4.75) | 2008 | Modelled | IHME |
| 4.06 (3.44 - 4.74) | 2007 | Modelled | IHME |
| 4.06 (3.43 - 4.75) | 2006 | Modelled | IHME |
| 4.06 (3.41 - 4.75) | 2005 | Modelled | IHME |
| 4.08 (3.43 - 4.76) | 2004 | Modelled | IHME |
| 4.11 (3.46 - 4.80) | 2003 | Modelled | IHME |
| 4.14 (3.48 - 4.86) | 2002 | Modelled | IHME |
| 4.17 (3.49 - 4.91) | 2001 | Modelled | IHME |
| 4.18 (3.50 - 4.93) | 2000 | Modelled | IHME |
| 4.14 (3.46 - 4.85) | 1999 | Modelled | IHME |
| 4.03 (3.36 - 4.76) | 1998 | Modelled | IHME |
| 3.9 (3.21 - 4.63) | 1997 | Modelled | IHME |
| 3.77 (3.08 - 4.53) | 1996 | Modelled | IHME |
| 3.67 (2.96 - 4.47) | 1995 | Modelled | IHME |
| 3.61 (2.92 - 4.41) | 1994 | Modelled | IHME |
| 3.55 (2.88 - 4.35) | 1993 | Modelled | IHME |
| 3.5 (2.82 - 4.29) | 1992 | Modelled | IHME |
| 3.46 (2.77 - 4.25) | 1991 | Modelled | IHME |
| 3.43 (2.76 - 4.25) | 1990 | Modelled | IHME |
| 5.4 (4.60 - 6.40) | 2015 | Survey/reported | Hagan et al, 2015 |
| 4.2 (3 - 4.20) | 2015 | Modelled | Blach et al, 2017 |
Showing out of
Show more
Prevalence of anti-HCV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 8.9 | 2018 | Survey/reported | Averhoff A et al, 2020 |
| 6.7 (5.60 - 7.30) | 2014 | Survey/reported | Gower et al, 2014 |
| 7.7 (6.70 - 8.90) | 2015 | Survey/reported | Hagan et al, 2015 |
Showing out of
Show more
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 69.1 (58 - 80.20) | 2015 | Modelled | Degenhardt L et al, 2017 |
Number of people living with chronic HCV (RNA+/cAg)
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 189,145 (152,158 - 234,386) | 1990 | Modelled | IHME |
| 189,378 (151,794 - 232,739) | 1991 | Modelled | IHME |
| 189,667 (152,858 - 232,224) | 1992 | Modelled | IHME |
| 189,925 (153,916 - 232,628) | 1993 | Modelled | IHME |
| 190,170 (154,070 - 232,486) | 1994 | Modelled | IHME |
| 190,436 (153,419 - 232,028) | 1995 | Modelled | IHME |
| 192,131 (157,016 - 230,965) | 1996 | Modelled | IHME |
| 195,391 (161,024 - 232,230) | 1997 | Modelled | IHME |
| 198,422 (165,310 - 234,105) | 1998 | Modelled | IHME |
| 199,668 (167,063 - 233,906) | 1999 | Modelled | IHME |
| 197,721 (165,738 - 233,113) | 2000 | Modelled | IHME |
| 193,196 (161,893 - 227,356) | 2001 | Modelled | IHME |
| 187,971 (157,824 - 220,643) | 2002 | Modelled | IHME |
| 182,620 (153,694 - 213,698) | 2003 | Modelled | IHME |
| 177,773 (149,755 - 207,605) | 2004 | Modelled | IHME |
| 173,939 (145,939 - 203,443) | 2005 | Modelled | IHME |
| 170,956 (144,435 - 199,838) | 2006 | Modelled | IHME |
| 168,331 (142,618 - 196,388) | 2007 | Modelled | IHME |
| 165,957 (140,493 - 194,074) | 2008 | Modelled | IHME |
| 163,743 (138,619 - 191,414) | 2009 | Modelled | IHME |
| 161,646 (136,897 - 189,245) | 2010 | Modelled | IHME |
| 157,354 (133,111 - 183,966) | 2011 | Modelled | IHME |
| 150,123 (126,902 - 176,936) | 2012 | Modelled | IHME |
| 142,151 (118,760 - 169,678) | 2013 | Modelled | IHME |
| 135,494 (111,978 - 164,223) | 2014 | Modelled | IHME |
| 132,088 (108,193 - 161,326) | 2015 | Modelled | IHME |
| 131,416 (106,772 - 160,080) | 2016 | Modelled | IHME |
| 130,730 (105,606 - 159,146) | 2017 | Modelled | IHME |
| 129,290 (104,180 - 157,477) | 2018 | Modelled | IHME |
| 127,352 (102,992 - 155,505) | 2019 | Modelled | IHME |
| 62,212 (49,691 - 78,314) | 1990 | Modelled | IHME |
| 63,597 (50,678 - 80,111) | 1991 | Modelled | IHME |
| 65,111 (52,046 - 81,997) | 1992 | Modelled | IHME |
| 66,734 (53,325 - 83,705) | 1993 | Modelled | IHME |
| 68,457 (54,934 - 85,569) | 1994 | Modelled | IHME |
| 70,270 (56,444 - 87,325) | 1995 | Modelled | IHME |
| 72,670 (58,685 - 90,337) | 1996 | Modelled | IHME |
| 75,915 (61,201 - 94,584) | 1997 | Modelled | IHME |
| 79,591 (64,253 - 99,392) | 1998 | Modelled | IHME |
| 83,238 (66,952 - 103,751) | 1999 | Modelled | IHME |
| 86,355 (69,591 - 107,389) | 2000 | Modelled | IHME |
| 89,022 (71,743 - 111,218) | 2001 | Modelled | IHME |
| 91,643 (73,806 - 114,636) | 2002 | Modelled | IHME |
| 94,134 (76,209 - 117,396) | 2003 | Modelled | IHME |
| 96,396 (78,126 - 120,309) | 2004 | Modelled | IHME |
| 98,326 (79,616 - 122,411) | 2005 | Modelled | IHME |
| 99,721 (80,947 - 124,370) | 2006 | Modelled | IHME |
| 100,593 (81,653 - 125,580) | 2007 | Modelled | IHME |
| 101,177 (82,217 - 125,797) | 2008 | Modelled | IHME |
| 101,746 (82,534 - 125,980) | 2009 | Modelled | IHME |
| 102,615 (83,133 - 126,931) | 2010 | Modelled | IHME |
| 103,736 (84,152 - 128,266) | 2011 | Modelled | IHME |
| 104,838 (84,931 - 129,592) | 2012 | Modelled | IHME |
| 105,931 (86,035 - 130,864) | 2013 | Modelled | IHME |
| 107,040 (86,961 - 132,069) | 2014 | Modelled | IHME |
| 108,171 (87,600 - 133,678) | 2015 | Modelled | IHME |
| 112,420 (91,420 - 137,926) | 2016 | Modelled | IHME |
| 116,812 (94,889 - 144,126) | 2017 | Modelled | IHME |
| 118,098 (95,720 - 145,804) | 2018 | Modelled | IHME |
| 119,150 (95,506 - 147,507) | 2019 | Modelled | IHME |
| 165,000 (120,000 - 169,000) | 2015 | Modelled | Blach et al, 2017 |
Showing out of
Show more
HCV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 10 (7.47 - 13.40) | 2019 | Modelled | IHME |
| 10.2 (7.72 - 13.50) | 2018 | Modelled | IHME |
| 10.2 (7.79 - 13.50) | 2017 | Modelled | IHME |
| 10.1 (7.84 - 13.10) | 2016 | Modelled | IHME |
| 9.71 (7.58 - 12.70) | 2015 | Modelled | IHME |
| 9.47 (7.33 - 12.30) | 2014 | Modelled | IHME |
| 9.52 (7.32 - 12.30) | 2013 | Modelled | IHME |
| 9.27 (7.09 - 12) | 2012 | Modelled | IHME |
| 9.11 (6.97 - 11.80) | 2011 | Modelled | IHME |
| 8.86 (6.78 - 11.50) | 2010 | Modelled | IHME |
| 8.5 (6.49 - 11) | 2009 | Modelled | IHME |
| 8.2 (6.25 - 10.50) | 2008 | Modelled | IHME |
| 7.82 (5.97 - 10.10) | 2007 | Modelled | IHME |
| 7.84 (6.06 - 10.10) | 2006 | Modelled | IHME |
| 7.89 (6.11 - 10) | 2005 | Modelled | IHME |
| 8.12 (6.32 - 10.30) | 2004 | Modelled | IHME |
| 8.01 (6.23 - 10.20) | 2003 | Modelled | IHME |
| 8.07 (6.32 - 10.20) | 2002 | Modelled | IHME |
| 8.06 (6.37 - 10.20) | 2001 | Modelled | IHME |
| 8.04 (6.36 - 10.20) | 2000 | Modelled | IHME |
| 7.73 (6 - 9.94) | 1999 | Modelled | IHME |
| 7.12 (5.46 - 9.19) | 1998 | Modelled | IHME |
| 6.36 (4.84 - 8.41) | 1997 | Modelled | IHME |
| 5.99 (4.46 - 7.94) | 1996 | Modelled | IHME |
| 6.01 (4.48 - 7.91) | 1995 | Modelled | IHME |
| 6.23 (4.62 - 8.29) | 1994 | Modelled | IHME |
| 6.09 (4.53 - 8.07) | 1993 | Modelled | IHME |
| 6.19 (4.65 - 8.42) | 1992 | Modelled | IHME |
| 6.07 (4.50 - 8.24) | 1991 | Modelled | IHME |
| 5.91 (4.30 - 8.07) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 367 (274 - 490) | 2019 | Modelled | IHME |
| 376 (286 - 501) | 2018 | Modelled | IHME |
| 381 (291 - 504) | 2017 | Modelled | IHME |
| 379 (295 - 494) | 2016 | Modelled | IHME |
| 368 (288 - 483) | 2015 | Modelled | IHME |
| 362 (281 - 471) | 2014 | Modelled | IHME |
| 367 (282 - 474) | 2013 | Modelled | IHME |
| 361 (276 - 467) | 2012 | Modelled | IHME |
| 359 (274 - 465) | 2011 | Modelled | IHME |
| 353 (270 - 457) | 2010 | Modelled | IHME |
| 343 (262 - 442) | 2009 | Modelled | IHME |
| 335 (256 - 430) | 2008 | Modelled | IHME |
| 324 (248 - 417) | 2007 | Modelled | IHME |
| 330 (255 - 424) | 2006 | Modelled | IHME |
| 338 (261 - 429) | 2005 | Modelled | IHME |
| 354 (276 - 450) | 2004 | Modelled | IHME |
| 356 (277 - 452) | 2003 | Modelled | IHME |
| 366 (287 - 463) | 2002 | Modelled | IHME |
| 374 (295 - 473) | 2001 | Modelled | IHME |
| 380 (301 - 482) | 2000 | Modelled | IHME |
| 373 (290 - 479) | 1999 | Modelled | IHME |
| 351 (269 - 452) | 1998 | Modelled | IHME |
| 319 (243 - 422) | 1997 | Modelled | IHME |
| 306 (227 - 405) | 1996 | Modelled | IHME |
| 312 (232 - 410) | 1995 | Modelled | IHME |
| 329 (243 - 437) | 1994 | Modelled | IHME |
| 326 (243 - 431) | 1993 | Modelled | IHME |
| 335 (252 - 456) | 1992 | Modelled | IHME |
| 332 (246 - 451) | 1991 | Modelled | IHME |
| 325 (237 - 445) | 1990 | Modelled | IHME |
| 425 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 34 (25 - 43) | 2019 | Modelled | IHME |
| 34 (26 - 43) | 2018 | Modelled | IHME |
| 34 (26 - 43) | 2017 | Modelled | IHME |
| 35 (26 - 44) | 2016 | Modelled | IHME |
| 35 (26 - 44) | 2015 | Modelled | IHME |
| 35 (26 - 44) | 2014 | Modelled | IHME |
| 35 (26 - 44) | 2013 | Modelled | IHME |
| 35 (27 - 44) | 2012 | Modelled | IHME |
| 36 (27 - 44) | 2011 | Modelled | IHME |
| 36 (27 - 45) | 2010 | Modelled | IHME |
| 36 (27 - 45) | 2009 | Modelled | IHME |
| 36 (27 - 45) | 2008 | Modelled | IHME |
| 36 (27 - 46) | 2007 | Modelled | IHME |
| 37 (28 - 46) | 2006 | Modelled | IHME |
| 38 (28 - 46) | 2005 | Modelled | IHME |
| 38 (28 - 47) | 2004 | Modelled | IHME |
| 37 (28 - 47) | 2003 | Modelled | IHME |
| 37 (27 - 47) | 2002 | Modelled | IHME |
| 37 (28 - 47) | 2001 | Modelled | IHME |
| 37 (27 - 47) | 2000 | Modelled | IHME |
| 37 (28 - 47) | 1999 | Modelled | IHME |
| 37 (27 - 47) | 1998 | Modelled | IHME |
| 37 (28 - 47) | 1997 | Modelled | IHME |
| 37 (28 - 47) | 1996 | Modelled | IHME |
| 37 (28 - 47) | 1995 | Modelled | IHME |
| 37 (28 - 47) | 1994 | Modelled | IHME |
| 37 (28 - 47) | 1993 | Modelled | IHME |
| 37 (28 - 46) | 1992 | Modelled | IHME |
| 37 (28 - 46) | 1991 | Modelled | IHME |
| 37 (28 - 46) | 1990 | Modelled | IHME |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 31 (16 - 271) | 2015 | Survey/reported | Georgia National Centre for Disease Control and Public Health, 2015; Curatio International Foundation, 2015; Eurasia Harm Reduction Network, 2015 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 3.9 (3.10 - 4.80) | 2015 | Survey/reported | Curatio International Foundation, 2015 |
HBV National Action Plan
HepB birth dose policy
Yes
Year of birth dose introduction
2003
Eligible for HBV generic medicines
HBV elimination goal
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
Risk-based, Birth cohort
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
None
Overview
HBV elimination goal
HCV elimination goal
Year of goal
2030
Prevalence (national)
Modelled
Survey/surveillance
Hepatitis related deaths (national)
Prevalence < 5
HBV
0.24
(%)
2019, latest modelled
(0.21 - 0.28(%))
IHME
No. of syringes/PWID/year
Survey/surveillance
HCV
31
2015
(16 - 271)
Georgia National Centre for Disease Control and Public Health, 2015; Curatio International Foundation, 2015; Eurasia Harm Reduction Network, 2015
Eligible for HBV generic medicines
Eligible for HCV generic medicines
